Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Jarajapu, Yagna P R ^a   Cai, Jun ^a   Yan, Yuanqing ^a   Calzi, Sergio ^a   Kielczewski, Jennifer L ^a   Hu, Ping ^b   Shaw, Lynn C ^a   Firth, Sue M ^c   Chan Ling, Tailoi ^b   Boulton, Michael E ^a   Baxter, Robert C ^c   Grant, Maria B ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CLAUDIN 5; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HORSERADISH PEROXIDASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SERINE; SOMATOMEDIN BINDING PROTEIN 3; THREONINE; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD RETINA BARRIER; CALCIUM CELL LEVEL; CELL DISRUPTION; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NEWBORN; NONHUMAN; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RETINA BLOOD VESSEL; SIGNAL TRANSDUCTION; VASODILATATION;

ANIMALS; BLOOD-RETINAL BARRIER; CADHERINS; CALCIUM; CEREBRAL ARTERIES; CLAUDIN-5; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FURA-2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INTERCELLULAR JUNCTIONS; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RETINAL DISEASES; RETINAL VESSELS; SCAVENGER RECEPTORS, CLASS B; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ARMORACIA RUSTICANA; MUS; RATTUS;

EID: 84863713673     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039398     Document Type: Article

References (53)

1. Rosenfeld RG, Hwa V, Wilson E, Plymate SR, Oh Y, (2000) The insulin-like growth factor-binding protein superfamily. Growth Horm IGF Res 10 Suppl A pp. S16-17.
2. Firth SM, Baxter RC, (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23: 824-854.
3. Domene HM, Bengolea SV, Jasper HG, Boisclair YR, (2005) Acid-labile subunit deficiency: phenotypic similarities and differences between human and mouse. J Endocrinol Invest 28: 43-46.
4. Butler AA, LeRoith D, (2001) Minireview: tissue-specific versus generalized gene targeting of the igf1 and igf1r genes and their roles in insulin-like growth factor physiology. Endocrinology 142: 1685-1688.
5. Phillips LS, Pao CI, Villafuerte BC, (1998) Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3. Prog Nucleic Acid Res Mol Biol 60: 195-265.
6. Fu P, Thompson JA, Bach LA, (2007) Promotion of cancer cell migration: an insulin-like growth factor (IGF)-independent action of IGF-binding protein-6. J Biol Chem 282: 22298-22306.
7. Hwa V, Oh Y, Rosenfeld RG, (1999) Insulin-like growth factor binding proteins: a proposed superfamily. Acta Paediatr pp. 37-45.
8. Zhu W, Shiojima I, Ito Y, Li Z, Ikeda H, et al. (2008) IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis. Nature 454: 345-349.
9. Lee WH, Wang GM, Yang XL, Seaman LB, Vannucci SI, (1999) Perinatal hypoxia-ischemia decreased neuronal but increased cerebral vascular endothelial IGFBP3 expression. Endocrine 11: 181-188.
10. Koga T, Endo H, Miyamoto Y, Mukai M, Akira S, et al. (2008) IGFBPs contribute to survival of pancreatic cancer cells under severely hypoxic conditions. Cancer Lett 268: 82-88.
11. Le Jan S, Le Meur N, Cazes A, Philippe J, Le Cunff M, et al. (2006) Characterization of the expression of the hypoxia-induced genes neuritin, TXNIP and IGFBP3 in cancer. FEBS Lett 580: 3395-3400.
12. Granata R, Trovato L, Lupia E, Sala G, Settanni F, et al. (2007) Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms. J Thromb Haemost 5: 835-845.
13. Alderton WK, Cooper CE, Knowles RG, (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 357: 593-615.
14. Ju WK, Gwon JS, Kim KY, Oh SJ, Kim SY, et al. (2001) Up-regulated eNOS protects blood-retinal barrier in the L-arginine treated ischemic rat retina. Neuroreport 12: 2405-2409.
15. Carmo A, Cunha-Vaz JG, Carvalho AP, Lopes MC, (2000) Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability. Nitric Oxide 4: 590-596.
16. El-Remessy AB, Behzadian MA, Abou-Mohamed G, Franklin T, Caldwell RW, et al. (2003) Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am J Pathol 162: 1995-2004.
17. Lu L, Xu H, Wang X, Guo G, (2009) Increased nitric oxide synthase activity is essential for electromagnetic-pulse-induced blood-retinal barrier breakdown in vivo. Brain Res 1264: 104-110.
18. Johnson PC, (1986) Autoregulation of blood flow. Circ Res 59: 483-495.
19. Chang KH, Chan-Ling T, McFarland EL, Afzal A, Pan H, et al. (2007) IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc Natl Acad Sci U S A 104: 10595-10600.
20. Shaw LC, Pan H, Afzal A, Calzi SL, Spoerri PE, et al. (2006) Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization. Gene Ther 13: 752-760.
21. Chan-Ling T, (1997) Glial, vascular, and neuronal cytogenesis in whole-mounted cat retina. Microsc Res Tech 36: 1-16.
22. Chan-Ling T, Tout S, Hollander H, Stone J, (1992) Vascular changes and their mechanisms in the feline model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 33: 2128-2147.
23. Jarajapu YP, Knot HJ, (2002) Role of phospholipase C in development of myogenic tone in rat posterior cerebral arteries. Am J Physiol Heart Circ Physiol 283: H2234-2238.
24. Yan X, Forbes BE, McNeil KA, Baxter RC, Firth SM, (2004) Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation. J Biol Chem 279: 53232-53240.
25. Cai J, Jiang WG, Grant MB, Boulton M, (2006) Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 281: 3604-3613.
26. Ingermann AR, Yang YF, Han J, Mikami A, Garza AE, et al. (2010) Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer. J Biol Chem 285: 30233-30246.
27. Heidary G, Vanderveen D, Smith L, (2009) Retinopathy of Prematurity: Current concepts in Molecular Pathogenesis. Seminars in Ophthalmology 24: 77-81.
28. Jarajapu YP, Kielczewski JL, McFarland EL, Cai J, Afzal A, et al. (2009) Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation. Circ Res 105: 897-905.
29. Watanabe H, Davis JB, Smart D, Jerman JC, Smith GD, et al. (2002) Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives. J Biol Chem 277: 13569-13577.
30. Mohanraj L OY, (2010) Impact of IGFBP-3 in human cardiovascular diseases. Endocrine Reviews.
31. Fleming I, Fisslthaler B, Dimmeler S, Kemp BE, Busse R, (2001) Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 88: E68-75.
32. Haynes MP, Li L, Sinha D, Russell KS, Hisamoto K, et al. (2003) Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem 278: 2118-2123.
33. Xu H, Zhao H, Tian W, Yoshida K, Roullet JB, et al. (2003) Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress. J Biol Chem 278: 11520-11527.
34. Kohler R, Heyken WT, Heinau P, Schubert R, Si H, et al. (2006) Evidence for a functional role of endothelial transient receptor potential V4 in shear stress-induced vasodilatation. Arterioscler Thromb Vasc Biol 26: 1495-1502.
35. Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, et al. (2007) Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 48: 5257-5265.
36. Kacimi R, Giffard RG, Yenari MA, (2011) Endotoxin-activated microglia injure brain derived endothelial cells via NF-kappaB, JAK-STAT and JNK stress kinase pathways. J Inflamm (Lond) 8: 7.
37. Kielczewski JL, Hu P, Shaw LC, Li Calzi S, Mames RN, et al. (2011) Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury. Am J Pathol 178: 1517-1528.
38. Oh Y, Muller HL, Pham H, Lamson G, Rosenfeld RG, (1993) Insulin-like growth factor binding protein (IGFBP)-3 levels in conditioned media of Hs578T human breast cancer cells are post-transcriptionally regulated. Growth Regul 3: 84-87.
39. Yamanaka Y, Fowlkes JL, Wilson EM, Rosenfeld RG, Oh Y, (1999) Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule. Endocrinology 140: 1319-1328.
40. Mishra S, Raz A, Murphy LJ, (2004) Insulin-like growth factor binding protein-3 interacts with autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and inhibits the AMF/PGI function. Cancer Res 64: 2516-2522.
41. Lee KW, Liu B, Ma L, Li H, Bang P, et al. (2004) Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem 279: 469-476.
42. Weinzimer SA, Gibson TB, Collett-Solberg PF, Khare A, Liu B, et al. (2001) Transferrin is an insulin-like growth factor-binding protein-3 binding protein. J Clin Endocrinol Metab 86: 1806-1813.
43. Lee KW, Ma L, Yan X, Liu B, Zhang XK, et al. (2005) Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77. J Biol Chem 280: 16942-16948.
44. Granata R, Trovato L, Garbarino G, Taliano M, Ponti R, et al. (2004) Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways. Faseb J 18: 1456-1458.
45. Seetharam D, Mineo C, Gormley AK, Gibson LL, Vongpatanasin W, et al. (2006) High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res 98: 63-72.
46. Li XA, Titlow WB, Jackson BA, Giltiay N, Nikolova-Karakashian M, et al. (2002) High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner. J Biol Chem 277: 11058-11063.
47. Fleming I, Bauersachs J, Fisslthaler B, Busse R, (1998) Ca2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ Res 82: 686-695.
48. Hirata K, Kuroda R, Sakoda T, Katayama M, Inoue N, et al. (1995) Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 25: 180-185.
49. Spoerri PE, Afzal A, Li Calzi S, Shaw LC, Cai J, et al. (2006) Effects of VEGFR-1, VEGFR-2, and IGF-IR hammerhead ribozymes on glucose-mediated tight junction expression in cultured human retinal endothelial cells. Mol Vis 12: 32-42.
50. Grimberg A, Cohen P, (2000) Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183: 1-9.
51. Key TJ, Appleby PN, Reeves GK, Roddam AW, (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11: 530-542.
52. Ikonen M, Liu B, Hashimoto Y, Ma L, Lee KW, et al. (2003) Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc Natl Acad Sci U S A 100: 13042-13047.
53. Schedlich LJ, Graham LD, O'Han MK, Muthukaruppan A, Yan X, et al. (2007) Molecular basis of the interaction between IGFBP-3 and retinoid X receptor: role in modulation of RAR-signaling. Arch Biochem Biophys 465: 359-369.